Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo
The ERK signalling pathway is activated in many cancers, however ERK1 and ERK2 are difficult to target pharmacologically. Here, the authors identify a small molecule inhibitor that binds covalently to the D-recruitment site of ERK and induces cell death and reduces tumour growth in mice.
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-12996-8 |